Mr
Scott
Fletcher

Patent Director

London Office

Engineering

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Scott specialises in obtaining patent and design protection and helping clients to develop and implement an IP strategy that supports their business aims. He works across all areas of engineering, in particular robotics, medical devices, Cleantech, consumer devices, FMCG, aerospace, and manufacturing.

The majority of Scott's work is with SMEs and start-ups, but he also has extensive experience working on large patent portfolios for multi-national clients. This includes a two-and-a-half year part-time secondment to the patents department of a multinational company where he gained experience in IP portfolio management, risk management, and IP exploitation. This combination of private practice and in-house experience enables Scott to offer pragmatic, business-led advice that helps his clients to succeed.

Qualifications

Patent Attorney

Chartered (UK)
European


MENG

MEng in Mechanical Engineering from University of Bath (1st Class)

Recognition

UK Patent Drafting Prize (2014)

Highest mark in the UK Patent Drafting Examination 2014.

Publications

Start-ups & IP, a case study: SleepCogni

View publication online

Conferences: 2021

March 2nd 2021

Child Health Technology Conference 2021

Attended

Event details

CSR

Scott is actively involved with training and mentoring trainee patent attorneys at HGF, including directly supervising work, giving tutorials, and mentoring groups through their preparation for the qualifying examinations. He also participates in the CIPA IP Clinics where inventors can get some initial IP advice free of charge to help them understand the benefits of IP and how it may help their business plans.

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 19th May 2022

HGF Complete webinar: comparison of registered and unregistered design rights procedures before the EUIPO and UKIPO

HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.